Considering the effects of E6 and E7, it is likely that the NF-κB pathway is activated in HPV-associated cancers by the pro-inflammatory signals coming from the tumour environment or by the change in the expression of proteins involved in NF-κB signalling. Here, NFKB1 is linked to cancer.